StockpollyBeta
Get App
Delisting riskPopularity #5,384
BGLC · NASDAQ · Industrial - Distribution

BioNexus Gene Lab (BGLC)

Distributor of composite-industry chemicals with Malaysian genomic screening and an ASEAN cancer-testing license.

$1.52
vs last close+0.06 (+4.11%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue322233223000
Cost of revenue222222222000
Gross profit000000000000
300021111110
Research & development000000000000
300120010110
Selling & marketing000002−11−1000
General & administrative30012−2010100
Other expenses000−100101000
Operating income−3000−10−1−1−1−1−10
000000000000
Interest income000000000000
Interest expense000000000000
Other non-operating income000000000000
Income before tax−3000−10−1−1−1−1−10
Income tax expense000000000000
Net income from continuing operations−3000−10−1−1−1−1−10
Net income−3000−10−1−1−1−1−10
EPS, basic−$1.56$0.17−$0.06$0.11−$0.75−$0.19−$0.35−$0.34−$0.39−$0.53−$0.22−$0.12
EPS, diluted−$1.56$0.17−$0.06$0.11−$0.75−$0.19−$0.35−$0.34−$0.39−$0.53−$0.22−$0.12
Weighted average shares, basic222222222222
Weighted average shares, diluted222222222222
EBITDA−2000−10−1−1−1−100
Depreciation & amortization000000000000
EBIT−3000−10−1−1−1−1−10